109 related articles for article (PubMed ID: 19478680)
1. Therapeutic effects of mucosal tolerance on experimental colitis in rats.
Shan-Shan Z; Yu-Lan L
Eur J Gastroenterol Hepatol; 2009 Oct; 21(10):1145-52. PubMed ID: 19478680
[TBL] [Abstract][Full Text] [Related]
2. [Therapeutic effects of mucosal tolerance on inflammatory bowel disease: experiment with rats].
Zhang SS; Liu YL
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(42):2969-72. PubMed ID: 18261325
[TBL] [Abstract][Full Text] [Related]
3. Treatment of experimental colitis by oral tolerance induction: a central role for suppressor lymphocytes.
Ilan Y; Weksler-Zangen S; Ben-Horin S; Diment J; Sauter B; Rabbani E; Engelhardt D; Chowdhury NR; Chowdhury JR; Goldin E
Am J Gastroenterol; 2000 Apr; 95(4):966-73. PubMed ID: 10763946
[TBL] [Abstract][Full Text] [Related]
4. Induction of ovalbumin-specific tolerance by oral administration of Lactococcus lactis secreting ovalbumin.
Huibregtse IL; Snoeck V; de Creus A; Braat H; De Jong EC; Van Deventer SJ; Rottiers P
Gastroenterology; 2007 Aug; 133(2):517-28. PubMed ID: 17681173
[TBL] [Abstract][Full Text] [Related]
5. Redirection of regulatory T cells with predetermined specificity for the treatment of experimental colitis in mice.
Elinav E; Waks T; Eshhar Z
Gastroenterology; 2008 Jun; 134(7):2014-24. PubMed ID: 18424268
[TBL] [Abstract][Full Text] [Related]
6. Hapten-induced model of murine inflammatory bowel disease: mucosa immune responses and protection by tolerance.
Elson CO; Beagley KW; Sharmanov AT; Fujihashi K; Kiyono H; Tennyson GS; Cong Y; Black CA; Ridwan BW; McGhee JR
J Immunol; 1996 Sep; 157(5):2174-85. PubMed ID: 8757344
[TBL] [Abstract][Full Text] [Related]
7. Different mechanisms regulate CD4(+) T cell independent induction of oral and nasal tolerance of CD8(+) T cells.
van den Berg H; Greuter M; Kraal G; den Haan JM
Immunobiology; 2010; 215(2):163-71. PubMed ID: 19278748
[TBL] [Abstract][Full Text] [Related]
8. Liver-associated lymphocytes expressing NK1.1 are essential for oral immune tolerance induction in a murine model.
Trop S; Samsonov D; Gotsman I; Alper R; Diment J; Ilan Y
Hepatology; 1999 Mar; 29(3):746-55. PubMed ID: 10051476
[TBL] [Abstract][Full Text] [Related]
9. Oral tolerance therapy in an experimental model of colitis.
Lee H; Barrett TA
Am J Gastroenterol; 2000 Apr; 95(4):861. PubMed ID: 10763923
[No Abstract] [Full Text] [Related]
10. Modulation of the colonic epithelial cell responses and amelioration of inflammation by CD80 blockade in TNBS colitis.
Srinivasan M; Summerlin DJ
Clin Immunol; 2009 Dec; 133(3):411-21. PubMed ID: 19811954
[TBL] [Abstract][Full Text] [Related]
11. Toll-like receptor 2 agonist Pam3CSK4 enhances the induction of antigen-specific tolerance via the sublingual route.
Lombardi V; Van Overtvelt L; Horiot S; Moussu H; Chabre H; Louise A; Balazuc AM; Mascarell L; Moingeon P
Clin Exp Allergy; 2008 Nov; 38(11):1819-29. PubMed ID: 18644025
[TBL] [Abstract][Full Text] [Related]
12. Immunomodulation of experimental colitis: the role of NK1.1 liver lymphocytes and surrogate antigens--bystander effect.
Shlomai A; Trop S; Gotsman I; Jurim O; Diment J; Alper R; Rabbani E; Engelhardt D; Ilan Y
J Pathol; 2001 Nov; 195(4):498-507. PubMed ID: 11745683
[TBL] [Abstract][Full Text] [Related]
13. Mucosally induced immunological tolerance, regulatory T cells and the adjuvant effect by cholera toxin B subunit.
Sun JB; Czerkinsky C; Holmgren J
Scand J Immunol; 2010 Jan; 71(1):1-11. PubMed ID: 20017804
[TBL] [Abstract][Full Text] [Related]
14. Colon epithelial cellular protein induces oral tolerance in the experimental model of colitis by trinitrobenzene sulfonic acid.
Dasgupta A; Ramaswamy K; Giraldo J; Taniguchi M; Amenta PS; Das KM
J Lab Clin Med; 2001 Oct; 138(4):257-69. PubMed ID: 11574820
[TBL] [Abstract][Full Text] [Related]
15. Oral tolerance: therapeutic implications for autoimmune diseases.
Faria AM; Weiner HL
Clin Dev Immunol; 2006; 13(2-4):143-57. PubMed ID: 17162357
[TBL] [Abstract][Full Text] [Related]
16. Amelioration of immune-mediated experimental colitis: tolerance induction in the presence of preexisting immunity and surrogate antigen bystander effect.
Gotsman I; Shlomai A; Alper R; Rabbani E; Engelhardt D; Ilan Y
J Pharmacol Exp Ther; 2001 Jun; 297(3):926-32. PubMed ID: 11356912
[TBL] [Abstract][Full Text] [Related]
17. Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses.
González MA; Gonzalez-Rey E; Rico L; Büscher D; Delgado M
Gastroenterology; 2009 Mar; 136(3):978-89. PubMed ID: 19135996
[TBL] [Abstract][Full Text] [Related]
18. Strategies to cure experimental autoimmune colitis using antigen-specific Foxp3+ regulatory T cells.
de Zoeten EF; Hancock WW
Gastroenterology; 2008 Jun; 134(7):2171-4. PubMed ID: 18482583
[No Abstract] [Full Text] [Related]
19. Oral dendritic cells mediate antigen-specific tolerance by stimulating TH1 and regulatory CD4+ T cells.
Mascarell L; Lombardi V; Louise A; Saint-Lu N; Chabre H; Moussu H; Betbeder D; Balazuc AM; Van Overtvelt L; Moingeon P
J Allergy Clin Immunol; 2008 Sep; 122(3):603-9.e5. PubMed ID: 18774396
[TBL] [Abstract][Full Text] [Related]
20. An oral drug delivery system targeting immune-regulating cells ameliorates mucosal injury in trinitrobenzene sulfonic acid-induced colitis.
Nakase H; Okazaki K; Tabata Y; Uose S; Ohana M; Uchida K; Nishi T; Debreceni A; Itoh T; Kawanami C; Iwano M; Ikada Y; Chiba T
J Pharmacol Exp Ther; 2001 Jun; 297(3):1122-8. PubMed ID: 11356937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]